LIU DONGFANG (Chief Medical Officer) sold 73.5% of their position (50K shares) of NUVATION BIO INC. on the open market
Open‑market sale worth $251.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/21/2026ACC: 0001937915-26-000004
Officer· Chief Medical Officer
Since Jul 2022
-50K
Net shares
Net seller
$251.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 100K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+50K
Price / share
$1.94
Trade value
$97K
% of position
277.8%
4/17/2026
18K→68K
Class A Common Stock
Direct
Shares
−50K
Price / share
$5.02
Trade value
$251K
% of position
73.5%
4/17/2026
68K→18K
Total
Net shares
+0.00
Net value
-$154K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 4/17/2026 | M · Option Exercise | +50K | $1.94 | $97K | 277.8% | 18K | 68K |
| Class A Common Stock Direct | 4/17/2026 | S · Sale | −50K | $5.02 | $251K | 73.5% | 68K | 18K |
| Total | +0.00 | -$154K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
50K shares
Shares
−50K
Strike price
1.94
Held after
430K
Exercisable
—
4/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock50K shares | 4/17/2026 | M · Option Exercise | −50K | 1.94 | — | 430K |